Answers are grounded in this paper and cite their sources.
Introduction : Diabetic foot ulcers (DFU) are a common complication of diabetes mellitus and a leading cause of infection, hospitalization, and lower-limb amputation. Conventional systemic antibiotics carry a risk of systemic toxicity and often achieve poor local wound concentrations. Local antibiotic delivery systems, particularly those using biologically active carriers such as vitamin D3, may enhance wound healing through combined antimicrobial and immunomodulatory effects. Aim and Objectives : To evaluate the efficacy of vitamin D3 granules as a local antibiotic delivery carrier in the management of infected diabetic foot ulcers. Materials and Methods : This prospective observational study included 35 diabetic patients with Wagner grade 2 or 3 forefoot ulcers. Patients received local application of vitamin D3 granules impregnated with tobramycin, with or without vancomycin, alongside standard wound care including debridement. Patients were followed up regularly, with outcomes assessed for wound healing, reduction in wound size, infection control, and serum vitamin D levels. Results : Complete ulcer healing was observed in 40% of patients, with a mean healing time of 21.57 days. Mean wound area decreased significantly from baseline to final follow-up. Serum vitamin D levels also improved significantly. The treatment achieved effective infection control and progressive wound healing without significant adverse effects. Conclusion : Vitamin D3 granules used as a local antibiotic delivery system appear to be a safe, cost-effective, and effective modality for managing diabetic foot ulcers. Larger randomized controlled trials are needed to confirm their role in enhancing wound healing and reducing infection.
No takes yet. Share an insight, caveat, or question.
Qamar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: